Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733

Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice

Lazarov, O., Lee, M., Peterson, D. A., & Sisodia, S. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09785.2002 · Cited by 302

Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path

Buxbaum, J. D., Thinakaran, G., Koliatsos, V. E., O’Callahan, J., Slunt, H. H., Price, D. L., & Sisodia, S. S. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09629.1998 · Cited by 266

Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage

Adle‐Biassette, Chrétien, Wingertsmann, Hery, H., Ereau, Scaravilli, Tardieu, & Gray (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00167.x · Cited by 233

Prevalence of Alzheimer plaques in AIDS

Esiri, M. M., Biddolph, S. C., & Morris, C. S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.29 · Cited by 225

Glial Cytokines as Neuropathogenic Factors in HIV Infection

Stanley, L. C., Mrak, R. E., Woody, R. C., Perrot, L. J., Zhang, S., Marshak, D. R., Nelson, S. J., & Griffin, W. S. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199405000-00003 · Cited by 150

β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology

Pike, C. J., Cummings, B. J., & Cotman, C. W. (1992) · Neuroreport · doi:10.1097/00001756-199209000-00012 · Cited by 131

Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo

Masliah, E., Westland, C., Rockenstein, E. M., Abraham, C. R., Mallory, M. E., Veinberg, I., Sheldon, E., & Mucke, L. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00553-2 · Cited by 119

Axonal Damage Revealed by Accumulation of β-APP in HIV-positive Individuals without AIDS

An, S., Giometto, B., Groves, M., Miller, R. F., Beckett, A. A. J., Gray, F., Tavolato, B. F., & Scaravilli, F. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199711000-00011 · Cited by 90

Axonal degeneration promotes abnormal accumulation of amyloid β-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse

Ichihara, N., Wu, J., Hua Chui, D., Yamazaki, K., Wakabayashi, T., & Kikuchi, T. (1995) · Brain Research · doi:10.1016/0006-8993(95)00729-a · Cited by 70

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics

Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200490 · Cited by 1,308

HIV-associated neurocognitive disorder

Clifford, D. B., & Ances, B. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70269-x · Cited by 698

Microbes and Alzheimer’s Disease

Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160152 · Cited by 532

The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics

Kent, S. A., Spires-Jones, T. L., & Durrant, C. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02196-w · Cited by 446

HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment

Eggers, C., Arendt, G., Hahn, K., Husstedt, I. W., Maschke, M., Neuen-Jacob, E., Obermann, M., Rosenkranz, T., Schielke, E., & Straube, E. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8503-2 · Cited by 338

Current understanding of HIV-associated neurocognitive disorders pathogenesis

Gannon, P. J., Khan, M. Z., & Kolson, D. L. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834695fb · Cited by 274

Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease

Pulliam, L., Sun, B., Mustapić, M., Chawla, S., & Kapogiannis, D. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0695-4 · Cited by 246

Alzheimer’s Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence

Gosztyla, M. L., Brothers, H. M., & Robinson, S. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171133 · Cited by 245

HIV-1 infection and cognitive impairment in the cART era: a review

Schouten, J., Cinque, P. M., Gisslén, M., Reiss, P., & Portegies, P. (2010) · AIDS · doi:10.1097/qad.0b013e3283437f9a · Cited by 249

Neurodegeneration and Ageing in the HAART Era

Brew, B. J., Crowe, S. M., LANDAY, A. L., Cysique, L. A., & Guillemin, G. J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9143-1 · Cited by 204

Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

HNRC, Achim, C. L., Adame, A., Dumaop, W., Everall, I. P., & Masliah, E. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9152-8 · Cited by 205

Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?

Honjo, K., van Reekum, R., & Verhoeff, N. P. L. G. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.12.001 · Cited by 208

CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection

Yadav, A., & Collman, R. G. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9174-2 · Cited by 203

CSF amyloid β42 and tau levels correlate with AIDS dementia complex

Brew, B. J., Pemberton, L. A., Blennow, K., Wallin, A., & Hagberg, L. (2005) · Neurology · doi:10.1212/01.wnl.0000183293.95787.b7 · Cited by 199

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease

Clifford, D. B., Fagan, A. M., Holtzman, D. M., Morris, J. C., Teshome, M., Shah, A. R., & Kauwe, J. S. K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c5b445 · Cited by 186

Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men

Becker, J. T., Kingsley, L., Mullen, J., Cohen, B. A., Martin, E. M., Miller, E. N., Ragin, A. B., Sacktor, N., Selnes, O. A., & Visscher, B. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd10e7 · Cited by 175

Nano-biosensors to detect beta-amyloid for Alzheimer's disease management

Kaushik, A. K., Jayant, R. D., Tiwari, S., Vashist, A., & Nair, M. G. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.01.065 · Cited by 167

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection

Peluso, M. J., Meyerhoff, D. J., Price, R. W., Peterson, J. J., Lee, E., Young, A. C., Walter, R. B., Fuchs, D., Brew, B. J., Cinque, P. M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit088 · Cited by 165

Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy

Anthony, I. C., Ramage, S. N., Carnie, F. W., Simmonds, P., & Bell, J. E. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0037-0 · Cited by 158

GluT4: A central player in hippocampal memory and brain insulin resistance

McNay, E. C., & Pearson-Leary, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113076 · Cited by 159

HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?

Cohen, R. A., Seider, T. R., & Navia, B. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0123-4 · Cited by 149

Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease

Harris, S. A., & Harris, E. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00048 · Cited by 154

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

Gisslén, M., Krut, J. J., Andréasson, U., Blennow, K., Cinque, P. M., Brew, B. J., Spudich, S., Hagberg, L., Rosengren, L., Price, R. W., et al. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-63 · Cited by 147

Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature

Lathe, R., Tsitrina, A. A., & Kotelevtsev, Y. V. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-36 · Cited by 141

Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)

Kurapati, K. R. V., Atluri, V. S. R., Samikkannu, T., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077624 · Cited by 130

Evolution of HIV dementia with HIV infection

Nath, A., Schiess, N., Venkatesan, A., Rumbaugh, J. A., Sacktor, N. C., & McArthur, J. C. (2008) · International Review of Psychiatry · doi:10.1080/09540260701861930 · Cited by 120

The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era

Xu, J., & Ikezu, T. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9136-0 · Cited by 120

The shifting patterns of HIV encephalitis neuropathology

Everall, I., Hansen, L. A., & Masliah, E. (2005) · Neurotoxicity Research · doi:10.1007/bf03033819 · Cited by 119

Factors affecting brain structure in men with HIV disease in the post-HAART era

Becker, J. T., Maruca, V., Kingsley, L., Sanders, J. M., Alger, J. R., Barker, P. B., Goodkin, K., Martin, E. M., Miller, E. N., Ragin, A. B., et al. (2011) · Neuroradiology · doi:10.1007/s00234-011-0854-2 · Cited by 117

Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: Antagonistic pleiotropy and premature brain aging

Chang, L.-H., Andres, M., Sadino, J., Jiang, C. S., Nakama, H., Miller, E. N., & Ernst, T. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.010 · Cited by 113

Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders

Levine, A. J., Quach, A., Moore, D. J., Achim, C. L., Soontornniyomkij, V., Masliah, E., Singer, E. J., Gelman, B. B., Nemanim, N. M., & Horvath, S. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0406-3 · Cited by 114

Activation of TRPML1 Clears Intraneuronal Aβ in Preclinical Models of HIV Infection

Bae, M. H., Patel, N. P., Xu, H., Lee, M., Tominaga, K., Nath, A., Geiger, J. D., Gorospe, M., Mattson, M. P., & Haughey, N. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0210-14.2014 · Cited by 113

Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview

Kurapati, K. R. V., Atluri, V. S. R., Samikkannu, T., Garcia, G., & Nair, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01444 · Cited by 110

Global HIV neurology

Thakur, K. T., Boubour, A., Saylor, D. R., Das, M., Bearden, D., & Birbeck, G. L. (2018) · AIDS · doi:10.1097/qad.0000000000001796 · Cited by 106

HIV-associated neurocognitive disorder

Smail, R. C., & Brew, B. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63849-6.00007-4 · Cited by 106

Neurobiology of HIV

Hult, B., Chana, G., Masliah, E., & Everall, I. (2008) · International Review of Psychiatry · doi:10.1080/09540260701862086 · Cited by 101

HIV Infection and Dementia in Older Adults

High, K. P., Valcour, V., & Paul, R. H. (2006) · Clinical Infectious Diseases · doi:10.1086/503565 · Cited by 101

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers

Soontornniyomkij, V., Moore, D. J., Gouaux, B. D., Soontornniyomkij, B., Tatro, E. T., Umlauf, A., Masliah, E., Levine, A. J., Singer, E. J., Vinters, H. V., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835a117c · Cited by 102

Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood–brain barrier endothelial cells

Manda, K. R., Banerjee, A., Banks, W. A., & Nuran Ercal, A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.029 · Cited by 100

Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system

Nath, A., & Sacktor, N. C. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000236614.51592.ca · Cited by 98

Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics

Shah, A. B., Gangwani, M. R., Chaudhari, N. S., Glazyrin, A., Bhat, H. K., & Kumar, A. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9646-0 · Cited by 100

Fate of microglia during HIV‐1 infection: From activation to senescence?

Chen, N. C., Partridge, A. T., Sell, C., Torres, C. A., & Martín‐García, J. (2016) · Glia · doi:10.1002/glia.23081 · Cited by 94

HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity

Hategan, A. P., Bianchet, M. A., Steiner, J. P., Karnaukhova, E., Masliah, E., Fields, A., Lee, M., Dickens, A. M., Haughey, N. J., Dimitriadis, E. K., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3379 · Cited by 93

Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management

Ellis, R. J., Marquine, M. J., Kaul, M., Fields, J. A., & Schlachetzki, J. C. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00879-y · Cited by 101

Neurocognitive Consequences of HIV Infection in Older Adults: An Evaluation of the “Cortical” Hypothesis

Scott, J. C., Woods, S. P., Carey, C. L., Weber, E., Bondi, M. W., & Grant, I. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9815-8 · Cited by 89

CD45 Deficiency Drives Amyloid-β Peptide Oligomers and Neuronal Loss in Alzheimer's Disease Mice

Zhu, Y., Hou, H., Rezai-Zadeh, K. P., Giunta, B. N., Ruscin, A., Gemma, C., Jin, J., Dragicevic, N., Bradshaw, P. C., Rasool, S., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3268-10.2011 · Cited by 90

Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer’s Disease: an Emerging Issue in Geriatric NeuroHIV

Milanini, B., & Valcour, V. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0361-0 · Cited by 95

Impact of HIV and aging on neuropsychological function

Wendelken, L. A., & Valcour, V. (2012) · Journal of NeuroVirology · doi:10.1007/s13365-012-0094-1 · Cited by 90

Increased frequency of α-synuclein in the substantia nigra in human immunodeficiency virus infection

Khanlou, N., Khanlou, N., Moore, D. J., Khanlou, N., Moore, D. J., Chana, G., Cherner, M., Lazzaretto, D., Dawes, S. E., Grant, I., et al. (2009) · Journal of NeuroVirology · doi:10.1080/13550280802578075 · Cited by 87

Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Aβ1–42 secretion in SH-SY5Y neural cells

Khan, M. B., Lang, M. J., Huang, M., Raymond, A., Bond, V. C., Shiramizu, B. T., & Powell, M. D. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0383-6 · Cited by 84

HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis

Kaul, M. (2007) · Frontiers in bioscience · doi:10.2741/2860 · Cited by 82

Pathogenesis of age-related HIV neurodegeneration

Mackiewicz, M., Overk, C., Achim, C. L., & Masliah, E. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00728-z · Cited by 89

HIV-Associated Neurological Disorders

Tan, I. L., & McArthur, J. C. (2011) · CNS Drugs · doi:10.2165/11597770-000000000-00000 · Cited by 82

11C-PiB Imaging of Human Immunodeficiency Virus–Associated Neurocognitive Disorder

Ances, B. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.761 · Cited by 78

HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?

Canet, G., Dias, C., Gabelle, A., Simonin, Y., Gosselet, F., Marchi, N., Makinson, A., Tuaillon, É., de Perre, P. V., Givalois, L., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00307 · Cited by 80

Genetic variation and function of the HIV-1 Tat protein

Spector, C., Mele, A. R., Wigdahl, B. L., & Nonnemacher, M. R. (2019) · Medical Microbiology and Immunology · doi:10.1007/s00430-019-00583-z · Cited by 82

Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy

Bhatia, R., Ryscavage, P., & Taiwo, B. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-011-0073-y · Cited by 80

Role of HIV in Amyloid Metabolism

Ortega, M., & Ances, B. M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9546-0 · Cited by 78

Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production

Chen, X., Hui, L., Geiger, N. H., Haughey, N. J., & Geiger, J. D. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.015 · Cited by 75

HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein

Kim, J., Yoon, J., & Kim, Y.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077972 · Cited by 76

The effects of illicit drugs on the HIV infected brain

Anthony, I. (2007) · Frontiers in bioscience · doi:10.2741/2762 · Cited by 74

Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda

Abassi, M., Morawski, B. M., Nakigozi, G. F., Nakasujja, N., Kong, X., Meya, D. B., Robertson, K., Gray, R. H., Wawer, M. J., Sacktor, N. C., et al. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0505-9 · Cited by 76

Incidence and Impact on Mortality of Severe Neurocognitive Disorders in Persons With and Without HIV Infection: A Danish Nationwide Cohort Study

Lescure, F.-X., Omland, L. H., Engsig, F. N., Roed, C., Gerstoft, J., Pialoux, G., Kronborg, G., Larsen, C. S., & Obel, N. (2010) · Clinical Infectious Diseases · doi:10.1093/cid/ciq041 · Cited by 72

Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease

The HNRP Group, Fazeli, P. L., Marquine, M. J., Dufour, C. A., Henry, B. L., Montoya, J. L., Gouaux, B. D., Moore, R. C., Letendre, S. L., Woods, S. P., et al. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1024-z · Cited by 81

Immunohistochemical Visualization of Amyloid-β Protein Precursor and Amyloid-β in Extra- and Intracellular Compartments in the Human Brain

Aho, L., Pikkarainen, M., Hiltunen, M., Leinonen, V., & Alafuzoff, I. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091681 · Cited by 71

Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics

Olivier, I. S., Cacabelos, R., & Naidoo, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113594 · Cited by 74

The semantic relatedness of cue–intention pairings influences event-based prospective memory failures in older adults with HIV infection

Woods, S. P., Dawson, M., Weber, E., Grant, I., & Ce, T. H. N. R. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903130737 · Cited by 70

Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV

Levine, A. J., Soontornniyomkij, V., Achim, C. L., Masliah, E., Gelman, B. B., Sinsheimer, J. S., Singer, E. J., & Moore, D. J. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0410-7 · Cited by 70

Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury

Yuan, N. Y., & Kaul, M. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09868-9 · Cited by 68

Pharmacokinetics and Pharmacodynamics of Antiretrovirals in the Central Nervous System

Calcagno, A., Perri, G. D., & Bonora, S. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0171-0 · Cited by 73

HIV, dementia and antiretroviral drugs: 30 years of an epidemic

Manji, H., Jäger, H. R., & Winston, A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304022 · Cited by 69

HIV Regulation of Amyloid Beta Production

Pulliam, L. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9151-9 · Cited by 65

Autophagy in Dementias

Kragh, C. L., Ubhi, K. K., Wyss‐Coray, T., & Masliah, E. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00545.x · Cited by 66

Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders

Irollo, E., Luchetta, J., Ho, C.-T., Nash, B., & Meucci, O. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03785-y · Cited by 66

Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology

Andras, I. E., Léda, A. R., García-Contreras, M., Bertrand, L., Park, M., Skowrońska, M., & Toborek, M. J. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.12.006 · Cited by 64

Elevated rates of mild cognitive impairment in HIV disease

Sheppard, D. P., Iudicello, J. E., Bondi, M. W., Doyle, K. L., Morgan, E. E., Massman, P. J., Gilbert, P. E., & Woods, S. P. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0366-7 · Cited by 64

Increased CDK5 Expression in HIV Encephalitis Contributes to Neurodegeneration via Tau Phosphorylation and Is Reversed with Roscovitine

Patrick, C., Crews, L. A., Desplats, P., Dumaop, W., Rockenstein, E. M., Achim, C. L., Everall, I., & Masliah, E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.033 · Cited by 62

Efavirenz Promotes β-Secretase Expression and Increased Aβ1-40,42 via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)

Brown, L. A. M., Jin, J., Ferrell, D., Sadic, E., Obregon, D. F., Smith, A. J., Tan, J., & Giunta, B. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095500 · Cited by 59

Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders

Rosenthal, J. F., & Tyor, W. R. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00735-0 · Cited by 60

Alzheimer's disease gene signature says: beware of brain viral infections

Porcellini, E., Carbone, I., Ianni, M., & Licastro, F. (2010) · Immunity & Ageing · doi:10.1186/1742-4933-7-16 · Cited by 57

HIV and Aging

Gebo, K. A. (2006) · Drugs & Aging · doi:10.2165/00002512-200623110-00005 · Cited by 59

Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer’s disease?

Fülöp, T., Witkowski, J. M., Larbi, A., Khalil, A., Herbein, G., & Frost, E. H. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00732-3 · Cited by 59

HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice.

Giunta, B. N., Hou, H., Zhu, Y., Rrapo, E., Tian, J., Mori, T., Commins, D., Singer, E. J., He, J. J., Fernandez, F., et al. (2009) · PubMed Central · Cited by 57

Erythropoietin plus insulin‐like growth factor‐I protects against neuronal damage in a murine model of human immunodeficiency virus‐associated neurocognitive disorders

Kang, Y., Digicaylioglu, M. H., Russo, R., Kaul, M., Achim, C. L., Fletcher, L., Masliah, E., & Lipton, S. A. (2010) · Annals of Neurology · doi:10.1002/ana.22070 · Cited by 58

Molecular Mechanisms Associated with Neurodegeneration of Neurotropic Viral Infection

Wongchitrat, P., Chanmee, T., & Govitrapong, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03761-6 · Cited by 65

HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin

Andras, I. E., Eum, S. Y., Huang, W., Zhong, Y., Hennig, B., & Toborek, M. J. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.11.004 · Cited by 56

The Use of Antimicrobial and Antiviral Drugs in Alzheimer’s Disease

Iqbal, U., Zeng, E., & Pasinetti, G. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144920 · Cited by 55

Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users

Smith, D. B., Peter Simmonds, K., & Bell, J. E. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-013-0225-3 · Cited by 54

Cognitively unimpaired HIV-positive subjects do not have increased11C-PiB

Ances, B. M., Christensen, J. J., Teshome, M., Taylor, J., Xiong, C., Aldea, P., Fagan, A. M., Holtzman, D. M., Morris, J. C., Mintun, M. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e7b66e · Cited by 53

The struggle of a good friend getting old: cellular senescence in viral responses and therapy

Kohli, J., Veenstra, I., & Demaria, M. (2021) · The EMBO Reports · doi:10.15252/embr.202052243 · Cited by 52

Tat peptides inhibit neprilysin

Daily, A., Nath, A., & Hersh, L. B. (2006) · Journal of NeuroVirology · doi:10.1080/13550280600760677 · Cited by 52

Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research

Thaney, V. E., Sánchez, A. B., Fields, J. A., Minassian, A., Young, J. W., Maung, R., & Kaul, M. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0584-2 · Cited by 52

HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein

Hategan, A. P., Masliah, E., & Nath, A. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00736-z · Cited by 52

A label-free electrochemical immunosensor for beta-amyloid detection

Kaushik, A. K., Shah, P., Vabbina, P. K., Jayant, R. D., Tiwari, S., Vashist, A., Yndart, A., & Nair, M. G. (2016) · Analytical Methods · doi:10.1039/c6ay01910b · Cited by 51

Extracellular Vesicles: A Possible Link between HIV and Alzheimer’s Disease-Like Pathology in HIV Subjects?

Kodidela, S., Gerth, K. A., Haque, S., Gong, Y., Ismael, S., Singh, A. K., Ishrat, T., & Kumar, S. (2019) · Cells · doi:10.3390/cells8090968 · Cited by 51

HIV, aging, and cognition: emerging issues.

Valcour, V. (2013) · Europe PMC (PubMed Central) · Cited by 50

The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease

Rubin, L. H., Sundermann, E. E., & Moore, D. J. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0702-9 · Cited by 53

Complications of HIV infection: a systems-based approach.

Chu, C., & Selwyn, P. A. (2011) · PubMed · Cited by 48

HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis

Sil, S., Hu, G., Liao, K., Niu, F., Callen, S. E., Periyasamy, P., Fox, H. S., & Buch, S. J. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000660 · Cited by 46

Antimicrobial α-defensins as multi-target inhibitors against amyloid formation and microbial infection

Zhang, Y., Liu, Y., Tang, Y., Zhang, D., He, H., Wu, J., & Zheng, J. (2021) · Chemical Science · doi:10.1039/d1sc01133b · Cited by 46

Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

Achim, C. L., Adame, A., Dumaop, W., EVERALL, I. P., & Masliah, E. (2009) · eScholarship (California Digital Library)

HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition

Morgello, S., Cortes, E. P., Gensler, G. R., Meloni, G., Jacobs, M. M., Murray, J., Borukov, V., & Crary, J. F. (2021) · AIDS · doi:10.1097/qad.0000000000002893 · Cited by 16

Intraneuronal β-Amyloid Accumulation: Aging HIV-1 Human and HIV-1 Transgenic Rat Brain

Li, H., McLaurin, K. A., Mactutus, C. F., Likins, B., Huang, W., Chang, S. L., & Booze, R. M. (2022) · Viruses · doi:10.3390/v14061268 · Cited by 14

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers

Soontornniyomkij, V., Moore, D. J., Gouaux, B. D., Soontornniyomkij, B., Tatro, E. T., Umlauf, A., Masliah, E., Levine, A. J., Singer, E. J., Vinters, H. V., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835a117c · Cited by 102

Beta-amyloid (Aβ) uptake by PET imaging in older HIV+ and HIV- individuals

Mohamed, M. A., Skolasky, R. L., Zhou, Y., Ye, W., Brašić, J. R., Brown, A. M., Pardo, C. A., Barker, P. B., Wong, D. F., & Sacktor, N. C. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00836-1 · Cited by 21